Download PDF
Exp Clin Endocrinol Diabetes 2014; 122(04): 231-235
DOI: 10.1055/s-0034-1367003
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Lower Melanin Content in the Skin of Type 1 Diabetic Patients and the Risk of Microangiopathy

M. Mackiewicz-Wysocka
1   Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland
,
A. Araszkiewicz
2   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
,
J. Schlaffke
2   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
,
S. Kuczynski
3   Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
,
I. Micek
3   Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
,
D. Zozulinska-Ziolkiewicz
2   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
› Author Affiliations
Further Information

Publication History

received 11 September 2013
first decision 30 December 2013

accepted 15 January 2014

Publication Date:
12 March 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Background:

Various skin diseases are commonly observed in diabetic patients. Typical biophysical properties of diabetic skin such as lower skin elasticity, decreased water content in stratum corneum, increased itching and sweating disturbances are reported. The aim of the study was to examine the distribution and intensity of skin pigmentation in diabetic patients in correlation with the metabolic control and with presence of microangiopathy.

Materials and methods:

The study was conducted on 105 patients (42 men and 63 women, median age 31), with type 1 diabetes (DM1). The control group of 53 healthy individuals (22 men and 31 women) was age- and sex-matched. Skin pigmentation was measured at 3 different locations of the body (cheek, dorsal surface of a forearm and dorsal surface of a foot) using Mexameter® MX 18. We calculated melanin index (MI) by the meter from the intensities of absorbed and reflected light at 880 nm.

Results:

Patients with DM1 had lower MI on the foot (173.2±38.8 vs. 193.4±52.7, p=0.016) as compared to controls. In the univariate analysis cheek MI was negatively related to HbA1c level (β=−4.53, p=0.01). Forearm MI was negatively associated with daily insulin dose (β=−0.58, p=0.01), BMI (β=−3.02, p<0.001), waist circumference (β=−0.75, p=0.009), serum TG concentration (β=−18.47, p<0.001) and positively with HDL cholesterol level (β=15.76, p=0.02). Diabetic patients with hypertension had lower foot MI values (β=−18.28, p=0.03). Lower MI was associated with the presence of diabetic neuropathy (β=−18.67, p=0.04) and retinopathy (β=−17.47, p=0.03).

Conclusions:

In conclusion, there seems to be loss of melanocytes in type 1 diabetes. The melanin content is related to glycemic control of diabetes and obesity. The lower melanin content the higher possibility of microangiopathy. This is a first report in the literature devoted to distribution of melanin in the skin of type 1 diabetic patients.

Key words

diabetes  - autoimmunity - skin - melanocytes - mexameter - advanced glycation end products
 

  • References

  • 1 Rao GS, Pai GS. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol 1997; 63: 232-234
    PubMedSearch in Google Scholar
  • 2 Sakai S, Kikuchi K, Satoch J et al. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol 2005; 153: 319-323
    CrossrefPubMedSearch in Google Scholar
  • 3 Seirafi H, Farsinejad K, Firooz A et al. Biophysical characteristics of skin in diabetes: a controlled study. J Eur Acad Dermatol Venereol 2009; 23: 146-149
    CrossrefPubMedSearch in Google Scholar
  • 4 Van den Driessche A, Eenkhoorn V, Van Gaal L et al. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med 2009; 67: 376-387
    PubMedSearch in Google Scholar
  • 5 Millington GW. Proopiomelanocortin (POMC): The cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 2006; 31: 407-412
    CrossrefPubMedSearch in Google Scholar
  • 6 Suzuki I, Tada A, Ollmann M et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to α-melanotropin. J Invest Dermatol 1997; 108: 838-842
    CrossrefPubMedSearch in Google Scholar
  • 7 Le Pape E, Passeron T, Giubellino A et al. Microarray analysis sheds light on the dedifferentiating role of agouti signalnprotein in murine melanocytes via the Mc1r. Proc Natl Acad Sci 2009; 106: 1802-1807
    CrossrefPubMedSearch in Google Scholar
  • 8 Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneous manifestations of diabetes mellitus. J Ayub Med Coll Abbottabad 2009; 21: 76-79
    PubMedSearch in Google Scholar
  • 9 Spravchikov N, Sizyakov G, Gartsbein M et al. Glucose Effects on Skin Keratinocytes. Implications for Diabetes Skin Complications. Diabetes 2001; 50: 1627-1635
    CrossrefPubMedSearch in Google Scholar
  • 10 Cardinali G, Ceccarelli S, Kovacs D et al. Keratinocyte Growth Factor Promotes Melanosome Transfer to Keratinocytes. J Invest Dermatol 2005; 125: 1190-1199
    CrossrefPubMedSearch in Google Scholar
  • 11 Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004; 17: 96-110
    CrossrefPubMedSearch in Google Scholar
  • 12 Virador VM, Muller J, Wu X et al. Influence of a-melanocyte-stimulating hormone and of ultraviolet radiation on the transfer of melanosomes to keratinocytes. FASEB J 2002; 16: 105-107
    PubMedSearch in Google Scholar
  • 13 Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-1992
    CrossrefPubMedSearch in Google Scholar
  • 14 Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D et al. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease. Exp Clin Endocrinol Diabetes 2010; 118: 478-484
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 2007; 30: 707-712
    CrossrefPubMedSearch in Google Scholar
  • 16 Thorn LM, Forsblom C, Fagerudd J et al. FinnDiane Study Group . Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycaemic control (the FinnDiane study). Diabetes Care 2005; 28: 2019-2024
    CrossrefPubMedSearch in Google Scholar
  • 17 Katsuki A, Sumida Y, Gabazza EC et al. Plasma levels of agouti-related protein are increased in obese men. J Clin Endocrinol Metab 2001; 86: 1921-1924
    CrossrefPubMedSearch in Google Scholar
  • 18 Nahon JL. The melanocortins and melanin-concentrating hormone in the central regulation of feeding behawior and energy homeostasis. C R Biol 2006; 329: 623-638
    CrossrefPubMedSearch in Google Scholar
  • 19 Cameron NE, Eaton SE, Cotter MA et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-1988
    CrossrefPubMedSearch in Google Scholar
  • 20 Joint Task Force of the E, the PNS . European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2010; 15: 79-92
    CrossrefPubMedSearch in Google Scholar
  • 21 Wierusz-Wysocka B, Zozulinska DA, Araszkiewicz A et al. Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes: Response to Molitch et al. Diabetes Care 2006; 29: 1176-1177
    PubMedSearch in Google Scholar
  • 22 Park K, Jin J, Hu Y et al. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Am J Pathol 2011; 178: 688-698
    CrossrefPubMedSearch in Google Scholar
  • 23 Araszkiewicz A, Zozulińska-Ziółkiewicz D, Meller M et al. Neurodegeneration of the retina in type 1 diabetic patients. Pol Arch Med Wewn 2012; 3: 464-470
    PubMedSearch in Google Scholar